Dr Charles Okafor

Research Fellow

Centre for Health Services Research
Faculty of Medicine


Dr. Charles Okafor is a postdoctoral research fellow at the Centre for Health Services Research, University of Queensland. His work involves the economic evaluation of healthcare technologies, and the application of health economics in public health and health services research. He previously worked in the Pharmaceutical Industry as a Research and Development Manager.

He holds a Bachelor of Pharmacy degree (BPharm) from the University of Nigeria; a Master of Clinical Pharmacy degree (MPharm) from Nnamdi Azikiwe University, Awka; and a PhD in Health Economics from Griffith University.

Charles is a member of the Health Technology Assessment International (HTAi); the International Society for Pharmacoeconomics and Outcome Research (ISPOR); and the International Society for Pharmacoepidemiology (ISPE).

Research Impacts

Charles’ recent research focused on the economic evaluation of healthcare interventions to inform decision-making. His experience gained him an opportunity to prepare a policy brief on rotavirus vaccination scale-up for the Copenhagen Consensus Center, USA Inc. at the 2019 Global Grand Challenges Summit to identify best buys for Africa. This effort supported the rotavirus vaccine introduction in Nigeria in 2022 after publishing results in 2021. The vaccine phase-1 implementation was successful in the nineteen northern states of Nigeria where the disease burden is high. The country expects to reduce at least 40% of morbidity and mortality associated with rotavirus infections among children. Other countries yet to introduce the vaccine in sub-Saharan Africa are currently considering its introduction.

He collaborated with the Australian Orthopaedic Association National Joint Replacement Registry to verify the cost-benefit of the registry to provide justification for its significant cost. The outcome of the project will ensure data quality of the registry, validity, and data analysis which will facilitate clinical improvement and safe innovation in arthroplasty surgeries.

Charles' recent project on the Maternal and Child Health Support program initiative has demonstrated the feasibility of engaging proprietary and patent medicine vendors to mitigate the high rate of under-five mortality rate in Nigeria. This initiative has been adopted as a policy but translation to practice is yet to be widely implemented.


  • Doctor of Philosophy of Health Economics, Griffith University


  • Chai, Gene G., Tu, Quyen, Cotta, Menino O., Bauer, Michelle J., Balch, Ross, Okafor, Charles, Comans, Tracy, Kruger, Peter, Meyer, Jason, Shekar, Kiran, Brady, Kara, Fourie, Cheryl, Sharp, Natalie, Vlad, Luminita, Whiley, David, Ungerer, Jacobus P. J., McWhinney, Brett C., Farkas, Andras, Paterson, David L., Clark, Julia E., Hajkowicz, Krispin, Raman, Sainath, Bialasiewicz, Seweryn, Lipman, Jeffrey, Forde, Brian M., Harris, Patrick N. A., Schlapbach, Luregn J., Coin, Lachlan, Roberts, Jason A. and Irwin, Adam D. (2024). Achievement of therapeutic antibiotic exposures using Bayesian dosing software in critically unwell children and adults with sepsis. Intensive Care Medicine, 50 (4), 1-9. doi: 10.1007/s00134-024-07353-3

  • Okafor, Charles E., Keramat, Syed Afroz, Comans, Tracy, Page, Amy T., Potter, Kathleen, Hilmer, Sarah N., Lindley, Richard I., Mangin, Dee, Naganathan, Vasi and Etherton-Beer, Christopher (2024). Cost-Consequence Analysis of Deprescribing to Optimize Health Outcomes for Frail Older People: A Within-Trial Analysis. Journal of the American Medical Directors Association, 25 (3), 539-544.e2. doi: 10.1016/j.jamda.2023.12.016

  • Okafor, Charles, Byrnes, Joshua, Stewart, Simon, Scuffham, Paul and Afoakwah, Clifford (2023). Cost effectiveness of strategies to manage atrial fibrillation in middle- and high-income countries: a systematic review. PharmacoEconomics, 41 (8), 913-943. doi: 10.1007/s40273-023-01276-5

View all Publications


Journal Article